Tempus AI's (TEM) "Neutral" Rating Reaffirmed at Piper Sandler

Piper Sandler reissued their neutral rating on shares of Tempus AI (NASDAQ:TEM - Free Report) in a report published on Tuesday,Benzinga reports. The brokerage currently has a $70.00 price target on the stock, up from their prior price target of $40.00.

Several other equities research analysts have also recently weighed in on TEM. Needham & Company LLC reissued a "buy" rating and issued a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Stifel Nicolaus cut Tempus AI from a "buy" rating to a "hold" rating and increased their target price for the stock from $45.00 to $65.00 in a report on Monday. JPMorgan Chase & Co. increased their price objective on Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Loop Capital lifted their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Finally, Bank of America downgraded Tempus AI from a "buy" rating to a "neutral" rating and increased their price target for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $54.22.

Tempus AI Price Performance

Shares of TEM traded down $9.58 during trading hours on Tuesday, reaching $68.04. The company's stock had a trading volume of 1,726,376 shares, compared to its average volume of 1,183,888. The firm has a 50 day moving average of $50.90. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 3.52.

Institutional Trading of Tempus AI

A number of hedge funds have recently made changes to their positions in TEM. NEA Management Company LLC purchased a new position in shares of Tempus AI in the second quarter valued at about $160,048,000. Novo Holdings A S purchased a new position in shares of Tempus AI in the second quarter valued at about $142,605,000. Revolution Growth Management Company Inc. purchased a new position in shares of Tempus AI in the second quarter valued at about $128,133,000. ARK Investment Management LLC increased its position in shares of Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock valued at $134,604,000 after buying an additional 1,855,459 shares during the period. Finally, Alphabet Inc. purchased a new position in shares of Tempus AI during the second quarter valued at about $54,289,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.